pancratistatin has been researched along with tamoxifen in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griffin, C; McLachlan-Burgess, A; McNulty, J; Pandey, S; Siedlakowski, P; Tirumalai, SS | 1 |
| Ray, S | 1 |
| Chatterjee, SJ; McNulty, J; Pandey, S | 1 |
3 other study(ies) available for pancratistatin and tamoxifen
| Article | Year |
|---|---|
Synergy of Pancratistatin and Tamoxifen on breast cancer cells in inducing apoptosis by targeting mitochondria.
Topics: Amaryllidaceae Alkaloids; Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Cell Division; Cell Nucleus; Female; Humans; Isoquinolines; Kinetics; Mitochondria; Tamoxifen | 2008 |
Synergy of Pancratistatin and Tamoxifen in inducing apoptosis in breast cancer cells.
Topics: Amaryllidaceae Alkaloids; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Drug Synergism; Female; Humans; Isoquinolines; Tamoxifen | 2008 |
Sensitization of human melanoma cells by tamoxifen to apoptosis induction by pancratistatin, a nongenotoxic natural compound.
Topics: Amaryllidaceae Alkaloids; Antineoplastic Agents, Hormonal; Apoptosis; Caspase 3; Cell Line, Tumor; DNA Repair; Drug Resistance, Neoplasm; Drug Synergism; Fibroblasts; Humans; Isoquinolines; Melanoma; Membrane Potential, Mitochondrial; Reactive Oxygen Species; Skin Neoplasms; Tamoxifen | 2011 |